Screener
Praxis Precision Medicines, Inc. PRAX Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
FAQ
- What is Praxis Precision Medicines, Inc.'s operating lease liabilities (total)?
- Praxis Precision Medicines, Inc. (PRAX) reported operating lease liabilities (total) of $1.4M in Q1 2026.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s operating lease liabilities (total) has grown at a -32.1% compound annual growth rate (CAGR), from $763K to $110K.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Praxis Precision Medicines, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude